World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer
09/23/2019
World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer
Topics: CTCs, Liquid biopsy, Precision Medicine, rare cells
Research Adds to Growing Evidence of Clinical Utility of CTCs for the management of Metastatic Breast Cancer Patients
Topics: CTCs, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer
Copy Number Alteration Profiling of Single Circulating Tumor Cells which May Be used to Predict Response to Therapy
Topics: CTCs, DEPArray NxT, NGS, CELLSEARCH, Liquid biopsy, Precision Medicine, low-pass, copy number alteration
Second World Summit on Cancer Heterogeneity and Precision Medicine Meets in Washington
Topics: FFPE, CTCs, Liquid biopsy, International experts, Menarini International Foundation, Precision Medicine, Cancer Heterogeneity, International conference
Liquid Biopsy Test for Circulating Tumor Cells Marks Its First Entry into U.S. Diagnostics Market
Topics: CTCs, deparray, CELLSEARCH, acquisition, CTC test, Liquid biopsy
Only FDA-Cleared CTC test to join Company’s Portfolio of Diagnostics
Topics: CTCs, single-cell isolation, deparray, CELLSEARCH
Genetic Profiles of Circulating Tumor Cells May Predict Drug Resistance and Clinical Outcomes
Topics: CTCs, lung cancer, deparray, SCLC